The role of nebivolol in the prevention of contrast-induced nephropathy

References (1)

1. Avcı E, Yeşil M, Bayata S, Postacı N, Arıkan E, Cirit M. The role of nebivolol in the prevention of contrast-induced nephropathy in patients with renal dysfunction. Anadolu Kardiyol Derg 2011; 11: 000-000 [CrossRef] 2. Toprak O, Cirit M, Tanrısev M, Yazıcı C, Canoz O, Sipahioğlu M, et al. Preventive effect of nebivolol on contrast-induced nephropathy in rats. Nephrol Dial Transplant 2008; 23: 853-9. 3. Tublin ME, Murphy ME, Tessler FN. Current concepts in contrast media-induced nephropathy. AJR AM J Roentgenol 1998; 171: 933-9. [CrossRef] 4. Funaki B. Contrast-induced nephropathy: what we know, what we think we know, and what we don’t know. Semin Intervent Radiol 2005; 22: 108-13. [CrossRef] 5. Shin DH, Choi DJ, Youn TJ, Yoon CH, Suh CW, Kim KI, et al. Comparison of contrast-induced nephrotoxicity of Iodixanol and Iopromide in patients with renal insufficiency undergoing coronary angiography. Am J Cardiol 2011; 108: 189-94. [CrossRef] 6. Friedewald VE, Goldfarb S, Laskey WK, Vetrovec GW, Roberts WC. The editor’s roundtable: contrast agents and risk for contrastinduced nephropathy. Am J Cardiol 2011; 107: 1848-55. [CrossRef]